Bio-Techne Corp (TECH) is listed on NASDAQ in Biotech Stocks. It is $72.36, -0.15%, with a $11.3B market cap. RSI is 58.5, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 58.5 Neutral
Market Cap $11.3B
Volume 1.6M
Fundamentals — 10-K FY 2026
Revenue $1.2B
Net Income --
EPS $1.16
Gross Margin 65.8%
Operating Margin 20.7%
P/E Ratio 62.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Herr Amy E. | Director | Sell | 6,636 | $48.28 | $320,386 | 2026 May 8 |
| Nusse Roeland | Director | Sell | 17,040 | $56.36 | $960,374 | 2025 Aug 25 |
| Baumgartner Robert V | Director | Sell | 17,040 | $56.21 | $957,818 | 2025 Aug 25 |
| Herr Amy E. | Director | Sell | 1,280 | $49.77 | $63,706 | 2025 Jun 9 |
| Herr Amy E. | Director | Sell | 1,860 | $65.96 | $122,686 | 2025 Feb 14 |
| Kelderman Kim | Chief Executive Officer | Sell | 13,392 | $77.28 | $1.0M | 2025 Jan 27 |
| Baumgartner Robert V | Director | Sell | 16,000 | $72.10 | $1.2M | 2024 Aug 8 |
| Higgins John L | Director | Sell | 4,000 | $83.84 | $335,360 | 2024 May 14 |
| Nusse Roeland | Director | Sell | 10,400 | $76.98 | $800,592 | 2024 Mar 7 |
| Nusse Roeland | Director | Sell | 8,939 | $80.32 | $717,980 | 2023 Aug 30 |
| Kummeth Charles R. | Chief Executive Officer | Sell | 80,000 | $88.36 | $7.1M | 2023 Jul 21 |
| Kummeth Charles R. | Chief Executive Officer | Sell | 322 | $83.00 | $26,726 | 2023 Jun 7 |
| Furlow Brenda S. | SVP - GENERAL COUNSEL | Sell | 8,250 | $82.11 | $677,402 | 2022 Dec 8 |
| Higgins John L | Director | Sell | 2,504 | $378.80 | $948,512 | 2022 Aug 11 |
| Higgins John L | Director | Sell | 1,600 | $364.98 | $583,964 | 2022 Jun 8 |
| Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Sell | 5,104 | $365.00 | $1.9M | 2022 Jun 7 |
| Baumgartner Robert V | Director | Buy | 300 | $352.55 | $105,765 | 2022 May 10 |
| Kelderman Kim | Pres. Diagnostics & Genom | Sell | 500 | $505.38 | $252,688 | 2021 Nov 19 |
| Eansor Norman David | President-Protein Sciences | Sell | 27,159 | $504.00 | $13.7M | 2021 Nov 12 |
| Hippel James | Chief Financial Officer | Sell | 9,022 | $526.49 | $4.7M | 2021 Nov 2 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $153.99 | 40.2 | $15.7B |
| | $105.31 | 69.1 | $12.0B |
| | $218.46 | 60.5 | $32.3B |
| | $134.97 | 69.6 | $10.2B |
| | $176.24 | 62.2 | $9.9B |
Take TECH further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put TECH in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Bio-Techne Corp next reports.
Set alerts on TECH
Get notified when Bio-Techne Corp hits your price targets or technical conditions are met.
Get Started Free